YOLFTbeta
Aimei Health Technology Co., Ltd Ordinary Share

Aimei Health Technology Co., Ltd Ordinary Share

AFJK · NASDAQ · Financial Services / Shell Companies

12.39USD-0.02 (-0.16%)

Price History

Full chart

Market Stats

Previous Close12.41
Open12.64
Day Range12.35 – 12.64
52-Week Range6.75 – 130.37
Volume1.92K
Market Cap38.60M
P/E (TTM)174.14
Forward P/E0.00
EPS0.07
Dividend Yield0.00%
Beta0.85
50-Day Avg12.09
200-Day Avg33.15

About

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other service sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

Company Details

  • SectorFinancial Services
  • IndustryShell Companies
  • CEOMr. Junheng Xie
  • Employees0
  • Headquarters10 East 53rd Street, New York, NY, United States, 10022, USA

Leadership

  • Mr. Junheng XieCEO, Secretary & Director · b. 1989
  • Mr. Heung Ming WongCFO & Director · b. 1969

Financials

Income Statement

Currency: USD2023-12-312024-12-312025-12-31
Total Revenue-00
Operating Income-28.46K-1.06M-835.76K
EBITDA171.39K-1.06M-835.76K
Net Income171.39K2.55M1.06M

Balance Sheet

Currency: USD2023-12-312024-12-312025-12-31
Total Assets70.47M73.81M12.10M
Total Liabilities714.84K1.51M4.06M
Total Equity69.76M72.31M8.04M
Cash580.72K28.21K2.93K
Total Debt-227.70K2.02M
Net Debt-580.72K199.49K2.02M

Cash Flow

Currency: USD2023-12-312024-12-312025-12-31
Operating Cash Flow--672.29K-565.10K
Investing Cash Flow-69.69M-277.70K63.58M
Financing Cash Flow70.27M397.48K-63.04M
Capital Expenditure000
Free Cash Flow--672.29K-565.10K
FCF to OCF-100.00%100.00%

Earnings

Report DateMar 31, 2024Jun 30, 2024Sep 30, 2024Mar 28, 2025May 14, 2025Aug 13, 2025Nov 18, 2025Dec 31, 2025Mar 31, 2026Aug 13, 2026Nov 17, 2026
EPS Estimate-----------
EPS Actual0.080.070.080.050.030.070.060.020.01-0.03-
Surprise-----------
Timing-----------

Key Statistics & Ratios

Market Cap38.60M
Enterprise Value40.63M
Trailing P/E174.14
Forward P/E0.00
Price / Sales0.00
Price / Book4.80
EPS0.07
Book Value-1.42
Revenue (TTM)0
Gross Profit (TTM)0
Profit Margin0.00%
Operating Margin0.00%
Return on Equity0.00%
Return on Assets-1.39%
Shares Outstanding3.17M
Shares Float1.44M
Beta0.85
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
32.02%
Insiders
64.96%
Retail / Other
3.02%

Top Institutional Holders

  • First Trust Capital Management L.P.
    680.00K21.48%
  • Glazer Capital, LLC
    133.74K4.22%
  • Clear Street Group Inc
    83.34K2.63%
  • Karpus Management Inc
    77.13K2.44%
  • Advisor Group Holdings, Inc.
    2380.01%
  • Federation des caisses Desjardins du Quebec
    1850.01%
  • Morgan Stanley - Brokerage Accounts
    500.00%
  • UBS Group AG
    140.00%
  • Oakmont Partners, LLC
    00.00%
  • Jane Street Group LLC
    00.00%
  • Geode Capital Management, LLC
    00.00%
  • JPMorgan Chase & Co
    00.00%

Top Fund Holders

  • Fidelity Nasdaq Composite Index
    5.81K0.18%